Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells

Non-small cell lung cancer (NSCLC) and hepatocellular carcinoma (HCC) are very common in certain population around the world. Despite the recent advances in their diagnosis and therapy, their prognosis remains poor due to the development resistance to drug. Although doxorubicin (DOX) is considered t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Rabou, Ahmed A, Ahmed, Hanaa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745235/
https://www.ncbi.nlm.nih.gov/pubmed/31350989
http://dx.doi.org/10.31557/APJCP.2019.20.7.2225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745235/
https://www.ncbi.nlm.nih.gov/pubmed/31350989
http://dx.doi.org/10.31557/APJCP.2019.20.7.2225

Ejemplares similares